Sealed Air (SEE) Q2 EPS Jumps 7%

Sealed Air (NYSE:SEE) reported strong Q2 2025 adjusted EPS of $0.89, significantly beating analyst expectations of $0.71, primarily due to disciplined cost execution and improved operating leverage. However, GAAP revenue declined 0.8% year-over-year to $1.33 billion amidst continued volume softness, especially in North America. A key concern is the sharp 60.9% year-over-year decline in first-half non-GAAP free cash flow to $81 million, largely due to incentive compensation and tax timing. Management reaffirmed full-year guidance, signaling ongoing caution regarding persistent volume pressures and the turnaround in the Protective segment.

Analysis

Sealed Air (NYSE:SEE) reported a mixed second quarter, characterized by strong bottom-line execution offset by persistent top-line weakness and a significant drop in cash flow. The company delivered a notable earnings beat, with adjusted EPS of $0.89 surpassing the $0.71 estimate, a 7.2% year-over-year increase driven primarily by cost discipline from its CTO2Grow program. This operational efficiency also lifted the adjusted EBITDA margin by 80 basis points. However, this profitability was achieved against a backdrop of declining GAAP revenue, which fell 0.8% year-over-year to $1.33 billion due to continued volume softness, particularly in North America. The performance divergence between its segments is stark: the Food division's sales were flat with an improved margin of 23.4%, while the Protective segment's sales fell 3% amid ongoing turnaround efforts, with its margin contracting to 17.8%. The most significant concern is the 60.9% year-over-year decline in first-half non-GAAP free cash flow to $81 million, attributed to incentive compensation and tax timing. Management's decision to reaffirm, rather than raise, full-year guidance underscores a cautious outlook on second-half demand.

Key Decisions for Investors

• Investors should closely monitor free cash flow generation in the second half to validate management's assertion that the 60.9% first-half decline was due to timing, as achieving the full-year target of $350-$450 million is critical for the investment thesis.
• Scrutinize the progress of the turnaround in the Protective segment, as its persistent 3% sales decline and contracting margins are a significant drag on overall performance, offsetting stability in the Food division.
• Weigh the strong Q2 earnings beat against management's cautious reaffirmation of guidance, which signals that underlying volume softness, especially in North America, remains a key headwind for the remainder of the year.
• Evaluate the sustainability of margin expansion, which is currently reliant on cost-cutting initiatives rather than organic volume growth, a dynamic that may face limits if top-line pressures persist.